SU JOK FOR DYSPNEA AND FATIGUE

NCT07746596 | Completed

• 1 other identifier: 2025-664
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

As the disease progresses, dyspnea and fatigue may increasingly interfere with daily activities, reduce patients' independence, and negatively affect their quality of life. Therefore, in addition to pharmacological treatment, there is a need for safe and supportive interventions to help alleviate these symptoms. This study aims to evaluate the effects of Su Jok therapy on dyspnea and fatigue in patients with chronic obstructive pulmonary disease (COPD). The findings are expected to provide evidence regarding the potential role of Su Jok therapy as a complementary intervention for symptom management. The results may contribute to improving patients' symptom control and quality of life while providing healthcare professionals with evidence to support clinical decision-making and nursing care.

Conditions

Fatigue Symptom; Chronic Obstructive Lung Disease; Dyspnea

Keywords

dyspnea; Fatigue symptom; Chronic Obstructive Lung Disease; sujok

Outcome Measures

Primary Outcomes (1)

• Dyspnea

  Dyspnea severity will be assessed using the Visual Analog Scale (VAS). Higher scores indicate greater dyspnea severity.

  Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.

Secondary Outcomes (1)

• fatigue severity

  Baseline and post-intervention (Day 5).

Study Arms (2)

Su Jok Therapy Group

EXPERIMENTAL

Participants in this group will receive routine COPD care plus five consecutive daily sessions of Su Jok therapy. Dyspnea and fatigue symptoms will be assessed daily using the Visual Analog Scale (VAS). Questionnaire data will be collected before the intervention (baseline) and after completion of the intervention (post-test).

Other: Su Jok Therapy

Control Group

NO INTERVENTION

Participants in this group will receive routine COPD care only. Dyspnea and fatigue symptoms will be assessed daily for five consecutive days using the Visual Analog Scale (VAS). Questionnaire data will be collected at baseline and after the study period (post-test).

Interventions

Su Jok Therapy OTHER

Su Jok therapy was administered by the researcher once daily for five consecutive days in addition to routine COPD care. The intervention involved stimulation of predefined Su Jok correspondence points on the hands according to the study protocol. Each session was performed using standardized procedures to ensure consistency throughout the study.

Su Jok Therapy Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 18 years or older. Diagnosed with chronic obstructive pulmonary disease (COPD). Able to communicate verbally. Expected to remain hospitalized for at least 5 days to ensure completion of the intervention.
• No major health condition other than COPD that could adversely affect activities of daily living (e.g., open wounds, cancer, or gastrointestinal disorders).
• Provided written informed consent to participate in the study. A Visual Analog Scale (VAS) score of 3 or higher for dyspnea and fatigue

You may not qualify if:

• Patients who do not provide written informed consent to participate in the study.
• Patients who are unable to communicate verbally. Patients with conditions that would prevent the application of Su Jok therapy to the hands, such as neuropathy, amputation, open wounds, or other hand disorders.

Sponsors & Collaborators

• Erzincan Binali Yildirim Universitesi: lead

Study Sites (1)

Erzincan Binali Yıldırım University

Erzincan, Turkey (Türkiye)

Location

Related Links

• Related Info

MeSH Terms

Conditions

Fatigue; Pulmonary Disease, Chronic Obstructive; Dyspnea

Condition Hierarchy (Ancestors)

Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Respiration Disorders; Signs and Symptoms, Respiratory

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: July 31, 2026
• First Posted: August 5, 2026
• Study Start: January 2, 2026
• Primary Completion: July 31, 2026
• Study Completion: August 1, 2026
• Last Updated: August 5, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)